Literature DB >> 15280169

Angiogenesis and pulmonary fibrosis: feast or famine?

Michael P Keane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15280169     DOI： 10.1164/rccm.2405007

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.

Authors:  William R Coward; Keira Watts; Carol A Feghali-Bostwick; Gisli Jenkins; Linhua Pang
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

Review 2.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

4.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

5.  Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Kyung-Hee Kim; Fabien Maldonado; Jay H Ryu; Patrick W Eiken; Thomas E Hartman; Brian J Bartholmai; Paul A Decker; Eunhee S Yi
Journal:  Respir Res       Date:  2010-04-14

6.  Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.

Authors:  Katerina M Antoniou; Giannoula Soufla; Athanasia Proklou; George Margaritopoulos; Christiana Choulaki; Rena Lymbouridou; Katerina D Samara; Demetrios A Spandidos; Nikolaos M Siafakas
Journal:  Clin Dev Immunol       Date:  2010-02-14

7.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

8.  Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.

Authors:  Stavros Garantziotis; Enrique Zudaire; Carol S Trempus; John W Hollingsworth; Dianhua Jiang; Lisa H Lancaster; Elizabeth Richardson; Lisheng Zhuo; Frank Cuttitta; Kevin K Brown; Paul W Noble; Koji Kimata; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

Review 9.  Pulmonary toxicity and fibrogenic response of carbon nanotubes.

Authors:  Amruta Manke; Liying Wang; Yon Rojanasakul
Journal:  Toxicol Mech Methods       Date:  2013-01-16       Impact factor: 2.987

10.  Balanced Wnt/Dickkopf-1 signaling by mesenchymal vascular progenitor cells in the microvascular niche maintains distal lung structure and function.

Authors:  Megan E Summers; Bradley W Richmond; Jonathan A Kropski; Sarah A Majka; Julie A Bastarache; Antonis K Hatzopoulos; Jeffery Bylund; Moumita Ghosh; Irina Petrache; Robert F Foronjy; Patrick Geraghty; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2020-10-21       Impact factor: 4.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.